Skip to main content
. 2017 Mar 16;12(3):e0174022. doi: 10.1371/journal.pone.0174022

Fig 4. The methylation and expression level of AKT1 in breast cancer patients with AKT1 mutations.

Fig 4

Boxplots show the average methylation (A) and expression (B) level of AKT1 in patient tumor tissues with or without AKT1 promoter mutations. P values were calculated using the Wilcoxon signed rank test.